Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination.
The immune response of 198 young Nigerian children protected against malaria by chemoprophylaxis with chloroquine to immunization with triple, poliomyelitis, measles, typhoid, meningococcal and BCG vaccines was compared with the immune response to vaccination of 185 control children. Good responses to triple, measles and BCG vaccines were shown by children in both groups; poorer responses were obtained to poliomyelitis, typhoid and meningococcal vaccines. The response to immunization of protected children was similar to that observed among control children for all the vaccines tested except for meningococcal polysaccharide vaccine. Protected children showed a significantly greater antibody response to both group A and group C meningococcal polysaccharides than control children. This finding supports the results of previous studies which have shown that the immune response to meningococcal polysaccharide vaccines is adversely affected both by acute malaria and by asymptomatic malaria parasitaemia.
D000917:Antibody Formation; D001500:BCG Vaccine; D002675:Child, Preschool; D002738:Chloroquine / Q000627:therapeutic use*; D004165:Diphtheria / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007223:Infant; D007231:Infant, Newborn; D008288:Malaria / Q000276:immunology* / Q000517:prevention & control; D008457:Measles / Q000276:immunology; D008589:Meningococcal Infections / Q000276:immunology; D009549:Nigeria; D011051:Poliomyelitis / Q000276:immunology; D012882:Skin Tests; D014376:Tuberculosis / Q000276:immunology; D014435:Typhoid Fever / Q000276:immunology; D014611:Vaccination
D001500:BCG Vaccine; D002738:Chloroquine